AIM
CGNT

Acrospire Investment Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Acrospire Investment Management’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,269
Closed -$36K – 2782
2017
Q1 		$36K Sell
20,269
-35,507
-64% -$70.2K 0.03% 1232
2016
Q4 		$112K Buy
+55,776
New +$114K 0.05% 849

Other funds holding CGNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acrospire Investment Management's CGNT Position: Q2 2017 in Review

Acrospire Investment Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2017, closing a stake of 20,269 shares — an estimated $36K sold.

Acrospire Investment Management first reported a position in CGNT in Q4 2016 and held it in 2 quarters. The position peaked at $112K in Q4 2016. 34 funds tracked by Wall St. Rank hold CGNT as of Q2 2017.

  • Acrospire Investment Management reported no remaining Cogentix Medical, Inc. position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 20,269 Cogentix Medical, Inc. shares in Q2 2017, an estimated $36K.
  • Acrospire Investment Management first reported a position in Cogentix Medical, Inc. in Q4 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Cogentix Medical, Inc. position peaked at $112K in Q4 2016.
  • 34 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.